EHS publications on Diabetes and the Heart

Results are published in the European Heart Journal :

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. Bartnik  M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, Standl E, Soler-Soler J, Öhrvik J, on behalf of the Euro Heart Survey Investigators. Eur Heart J 2004;25:1880-90.

M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L . Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004;25:1990-7.

Dotevall A, Rosengren A, Bartnik M, Malmberg K, Öhrvik J, Simoons M, Rydén L. Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease. Eur Heart J. 2007; 28: 310 – 315.

Other Journals:

Lenzen M, Rydén L, Öhrvik J, Bartnik M, Malmberg K, Scholte op Reime W, Simmons M L. Diabetes known or newly detected, but not impaired glucose regulation has a negative influence on 1-years outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Europ Heart J 2006; 27:2969-2974.

Bartnik M, Rydén L, Malmberg K, Öhrvik J, Pyörälä K, Standl E, Ferrari R, Simoons M, Soler-Soler J. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease. A report from the Euro Heart Survey on diabetes and the heart. Heart 2007; 93:72-77.  

Anselmino M, Bartnik M, Malmberg K, Rydén L on behalf of the Euro Heart Survey Investigators. Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the heart. Eur J Cardiovasc Prev Rehab 2007; 14: 28-36.

Anselmino M, Malmberg K, Öhrvik J, Rydén L on behalf of the Euro Heart survey Investigators. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease. A report from the Euro Heart Survey on Diabetes and the Heart. Eur J Cardiovasc Prev Rehabil. 2008;15:216-223.

Anselmino M, Öhrvik J, Malmberg K, Standl E, Rydén L on behalf of the Euro Heart Survey Investigators. Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart. Europ Heart J. 2008; 29:177-184.